Stories about Sequencing

Subscribe to Sequencing

03.08.2020 – 17:12

Helmholtz Zentrum München

AI & single-cell genomics: New software predicts cell fate

Visit scVelo.org

more
27.04.2020 – 14:01

Technische Universität München
In the hunt for new treatments against the coronavirus

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161/ 71-3207 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35999/ High resolution images: https://mediatum.ub.tum.de/1544195 In the hunt for new treatments against the coronavirus Researchers develop software for drug repurposing Currently, the corona pandemic is ...

more
30.01.2020 – 08:01

Abcam plc
Transaction adds comprehensive gene editing capabilities and engine to drive expansion of Abcam's 'off-the-shelf' edited cell line portfolio

Cambridge, England and Milpitas, California (ots/PRNewswire) - Abcam plc, a global innovator in life science reagents and tools, is today pleased to announce the asset purchase of the gene editing platform and oncology product portfolio of Applied StemCell, Inc. (ASC) for life science research and diagnostic ...

more
06.11.2019 – 09:30

Hitachi Medical Systems Europe Holding AG

2
Hitachi and Centre Léon Bérard cancer center in Lyon to launch a research collaboration in the fight against cancer with AI

more
03.06.2019 – 09:00

Debiopharm International SA
Caris Life Sciences Partners with Debiopharm International SA to Develop Companion Diagnostic for Detection of Rare FGFR Fusions Using Novel Molecular Intelligence (MI) Transcriptome(TM)

Irving, Texas (ots) - Caris to develop CDx for Debiopharm's FUZE Phase II Pivotal Trial of Debio 1347 in solid tumor patients with FGFR fusions Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced that it has entered into a strategic ...

more
03.05.2019 – 13:52

Helmholtz Zentrum München

What the wheat genome tells us about wars

Would you like to read the message online? This way!

more
04.01.2019 – 06:01

Sophia Genetics
SOPHiA GENETICS Raises $77 Million to Accelerate the Democratization of Data-Driven Medicine

San Francisco (ots/PRNewswire) - SOPHiA GENETICS, a leading health tech company, announced today the closing of a $77 million investment round to accelerate the democratization of Data-Driven Medicine. The round was led by Generation Investment Management, a pioneer of sustainable investing, with offices in London and San Francisco. Generation were joined by Idinvest ...

more

1